Abstract

Deep brain stimulation (DBS) is a surgical treatment in which stimulation electrodes are permanently implanted in basal ganglia to treat motor fluctuations and symptoms of Parkinson’s disease (PD). Subthalamic nucleus (STN) and globus pallidus internus (GPi) are the commonly used targets for DBS in PD. Many studies have compared motor and non-motor outcomes of DBS in both targets. However, the selection of PD patients for DBS targets is still poorly studied. Therefore, we performed this narrative review to summarize published studies comparing STN DBS and GPi DBS. GPi DBS is better for patients with problems in speech, mood, or cognition while STN DBS is better from an economic point of view as it allows much reduction in antiparkinson medications and less battery consumption.

Highlights

  • BackgroundParkinson's disease (PD) is a motor disorder characterized by progressive degeneration of dopaminergic neurons in the basal ganglia (BG)

  • There was no significant difference between Subthalamic nucleus (STN) Deep brain stimulation (DBS) and globus pallidus internus (GPi) DBS in UPDRS III motor score

  • Current evidence suggests that there is no significant difference between STN DBS and GPi DBS in terms of motor improvement on the UPDRS III score STN DBS allows more reduction in antiparkinsonian medication

Read more

Summary

Introduction

Parkinson's disease (PD) is a motor disorder characterized by progressive degeneration of dopaminergic neurons in the basal ganglia (BG). This degeneration causes overactivity of subthalamic nucleus (STN) leading to increased globus pallidus internus (GPi) output, which causes PD symptoms. Pharmacological treatments enhance the dopaminergic action in the BG They reduce PD symptoms that are mainly due to lack of dopamine. There is a need to summarize the available evidence to help neurologists select patients for DBS targets. We performed this narrative review to summarize published meta-analyses and randomized controlled trials (RCTs) comparing STN DBS and GPi DBS.

Design
29 Patients with PD
Conclusions
Findings
Disclosures
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.